EpiPen

Illinois passes bill requiring insurance companies to cover EpiPens for kids

Published:
Updated:
Illinois Gov. JB Pritzker has signed a bill into law that requires insurance companies to pay for EpiPens for kids.Read more

Univ. of Maryland puts EpiPens in campus dining halls

Published:
Updated:
The university began installing EpiPens in campus cafeterias last week next to AED devices.Read more

Generic drugmaker to sell alternative to EpiPen injectors

Published:
Updated:
Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year.Read more


FDA extending EpiPen expiration dates due to shortage

Published:
Updated:
The FDA is extending the expiration dates for some EpiPens by four months. The decision comes in the midst of a national shortage of the life-saving allergy drugs.Read more

Don't toss your EpiPen yet. The FDA is extending some expiration dates

Published:
Updated:
The FDA is extending the expiration dates for some EpiPens by four months.Read more

FDA approves first authorized generic competitor to EpiPen

Published:
Updated:
The FDA has approved the first authorized, generic competitor to EpiPen, which could lead to lower prices.Read more

FDA approves new, cheaper rival to EpiPen allergy shot

Published:
Updated:
U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.Read more

Anti-allergy medicine EpiPen recall expands to US

Published:
Updated:
A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy...Read more

CVS puts out generic competitor to EpiPen at a 6th the price

Published:
Updated:
CVS is now selling a rival generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was...Read more


Mylan to pay $465M settlement over Medicaid EpiPen rebates

Published:
Updated:
Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection.Read more

EpiPen maker's CEO on the hot seat

Published:
Updated:
On Wednesday, the CEO of the company that makes EpiPens testified about the dramatic price increases before Congress. Read more